<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04106336</url>
  </required_header>
  <id_info>
    <org_study_id>rTMS in cannabis use disorder</org_study_id>
    <nct_id>NCT04106336</nct_id>
  </id_info>
  <brief_title>Cortical Excitability and Role of rTMS in Cannabis Use Disorder</brief_title>
  <official_title>Cortical Excitability and Role of rTMS in Cannabis Use Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in
      cannabis use disorder
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of role of rTMS for reducing cannabis craving</measure>
    <time_frame>1 year</time_frame>
    <description>Incidenc of cannabis craving after rTMS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estimation of cortical excitability in cannabis addict</measure>
    <time_frame>1 year</time_frame>
    <description>Incidence of cannabis craving after cortical excitability</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cannabis Use Disorder, Moderate</condition>
  <arm_group>
    <arm_group_label>non cannabis addict</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>30 non cannabis addict will be control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cannabis addict</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 cannabis addict will undergo rTMS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <description>Repetitive transcranial magnetic stimulation (rTMS) will be done for cannabis addict</description>
    <arm_group_label>cannabis addict</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18to 50 years of age

          -  cannabis use disorder according to DSM 5 definition

          -  clear consent to participate in study

        Exclusion Criteria:

          -  cardiac peacemaker

          -  metal implant in the head as participate will be applied to magnetic field of TMS

          -  current intake of any medication affect cognition (as anti psychotic and anti
             epileptic)

          -  current history of neurological , psychiatric or general medical disease .current or
             previous drug (other than cannabis )or alcohol abuse or participation in another trial
             during the past 8 weeks .

          -  age younger than 18 and older than 50 years
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 23, 2019</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2019</study_first_posted>
  <last_update_submitted>September 25, 2019</last_update_submitted>
  <last_update_submitted_qc>September 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Asmaa Omar Radwan Helal</investigator_full_name>
    <investigator_title>Asmaa Omar Radwan Helal</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

